Exact Mass: 572.4189

Pancuronium

C35H60N2O4+2 (572.4553)

D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents > D009466 - Neuromuscular Blocking Agents M - Musculo-skeletal system > M03 - Muscle relaxants > M03A - Muscle relaxants, peripherally acting agents D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists C78281 - Agent Affecting Musculoskeletal System > C29696 - Muscle Relaxant

Dihydroxylycopene/ OH-Rhodopin

C40H60O2 (572.4593)

7,8-Dihydroparasiloxanthin

C40H60O2 (572.4593)

7,8-Dihydroparasiloxanthin is found in fishes. 7,8-Dihydroparasiloxanthin is a constituent of skin and fin of Japanese catfish (Parasilurus asotus). Constituent of skin and fin of Japanese catfish (Parasilurus asotus). 7,8-Dihydroparasiloxanthin is found in fishes.

Ganoderic acid W

C34H52O7 (572.3713)

Ganoderic acid W is found in mushrooms. Ganoderic acid W is a constituent of Ganoderma lucidum (reishi).

Ganoderic acid Ma

C34H52O7 (572.3713)

Ganoderic acid Ma is found in mushrooms. Ganoderic acid Ma is a metabolite of Ganoderma lucidum (reishi). Metabolite of Ganoderma lucidum (reishi). Ganoderic acid Ma is found in mushrooms.

(3b,5a,22E,24S)-Stigmasta-7,22,25-trien-3-ol 3-glucoside

C35H56O6 (572.4077)

(3b,5a,22E,24S)-Stigmasta-7,22,25-trien-3-ol 3-glucoside is found in fruits. (3b,5a,22E,24S)-Stigmasta-7,22,25-trien-3-ol 3-glucoside is a constituent of Cucurbita pepo and Momordica charantia (bitter melon). Constituent of Cucurbita pepo and Momordica charantia (bitter melon). (3b,5a,22E,24S)-Stigmasta-7,22,25-trien-3-ol 3-glucoside is found in fruits.

22-Angeloylbarringtogenol C

C35H56O6 (572.4077)

22-Angeloylbarringtogenol C is found in tea. 22-Angeloylbarringtogenol C is a constituent of Camellia sinensis var. assamica (Assam tea). Constituent of Camellia sinensis variety assamica (Assam tea). 22-Angeloylbarringtogenol C is found in tea.

5,6-Dihydro-5,6-dihydroxy-y,y-carotene

C40H60O2 (572.4593)

5,6-Dihydro-5,6-dihydroxy-carotene is a carotenoid found in human fluids. Carotenoids are isoprenoid molecules that are widespread in nature and are typically seen as pigments in fruits, flowers, birds and crustacea. Animals are unable to synthesise carotenoids de novo, and rely upon the diet as a source of these compounds. Over recent years there has been considerable interest in dietary carotenoids with respect to their potential in alleviating age-related diseases in humans. This attention has been mirrored by significant advances in cloning most of the carotenoid genes and in the genetic manipulation of crop plants with the intention of increasing levels in the diet. Studies have shown an inverse relationship between the consumption of certain fruits and vegetables and the risk of epithelial cancer. Since carotenoids are among the micronutrients found in cancer preventive foods, detailed qualitative and quantitative determination of these compounds, particularly in fruits and vegetables and in human plasma, have recently become increasingly important. (PMID: 1416048, 15003396). 5,6-Dihydro-5,6-dihydroxy-carotene is a carotenoid found in human fluids.

Vitamin D2 3-glucuronide

C34H52O7 (572.3713)

Vitamin D2 3-glucuronide is a natural human metabolite of Vitamin D2 generated in the liver by UDP glucuonyltransferase. Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys. Vitamin D2 3-glucuronide is a natural human metabolite of Vitamin D2 generated in the liver by UDP glucuonyltransferase. D018977 - Micronutrients > D014815 - Vitamins > D004872 - Ergocalciferols

3'-N-Acetyl-4'-O-(14-methylpentadecanoyl)fusarochromanone

C33H52N2O6 (572.3825)

3-N-Acetyl-4-O-(14-methylpentadecanoyl)fusarochromanone is produced by Fusarium equiseti. Production by Fusarium equiseti

Dmap-ethyl-paf

C30H57N2O6P (572.3954)

DG(10:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0)

C35H56O6 (572.4077)

DG(10:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/10:0/0:0)

C35H56O6 (572.4077)

DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(10:0/0:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4))

C35H56O6 (572.4077)

DG(10:0/0:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0/10:0)

C35H56O6 (572.4077)

DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(10:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0)

C35H56O6 (572.4077)

DG(10:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/10:0/0:0)

C35H56O6 (572.4077)

DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(10:0/0:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7))

C35H56O6 (572.4077)

DG(10:0/0:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0/10:0)

C35H56O6 (572.4077)

DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(10:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0)

C35H56O6 (572.4077)

DG(10:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/10:0/0:0)

C35H56O6 (572.4077)

DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(10:0/0:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14))

C35H56O6 (572.4077)

DG(10:0/0:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0/10:0)

C35H56O6 (572.4077)

DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(10:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0)

C35H56O6 (572.4077)

DG(10:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/10:0/0:0)

C35H56O6 (572.4077)

DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(10:0/0:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17))

C35H56O6 (572.4077)

DG(10:0/0:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0/10:0)

C35H56O6 (572.4077)

DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(10:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0)

C35H56O6 (572.4077)

DG(10:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/10:0/0:0)

C35H56O6 (572.4077)

DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(10:0/0:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17))

C35H56O6 (572.4077)

DG(10:0/0:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0/10:0)

C35H56O6 (572.4077)

DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

3-epi-Skimmiarepin A

C35H56O6 (572.4077)

E-Coumaroyltaraxerol

C39H56O3 (572.4229)

3alpha-Carboxyacetoxyquercinic acid

C34H52O7 (572.3713)

3-(Z)-Coumaroyllupeol

C39H56O3 (572.4229)

3-O-(Z)-Coumaroyl beta-amyrin

C39H56O3 (572.4229)

(4S,5S,6S,4S,5S,6S)-5,6,5,6-Tetrahydro-beta,beta-carotene-4,4-diol

C40H60O2 (572.4593)

SNF-4794-12

C31H56O7S (572.3747)

Carboxyacetylquercinic acid

C34H52O7 (572.3713)

1,1-Dihydroxylycopene

C40H60O2 (572.4593)

(2R,6R)-6-[(3R,10S,12S,13R,17R)-3-(2-carboxyacetyl)oxy-12-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-3-methylideneheptanoic acid

C34H52O7 (572.3713)

4beta,9alpha,20-trihydroxy-13alpha-pentadecanoate-1,6-tigliadien-3-one

C35H56O6 (572.4077)

butyl ganoderate B

C34H52O7 (572.3713)

Schiwalligenin A4

C35H56O6 (572.4077)

lupa-20(29)-ene-3-O-alpha-L-rhamnopyranoside

C36H60O5 (572.4441)

arundinol

C39H56O3 (572.4229)

Barringtogenol B

C35H56O6 (572.4077)

22-O-(3,3-dimethylacryloyl)-A1-barrigenol|22-O-(3-Methyl-2-butenoyl) -(3beta,15alpha,16alpha,22alpha)-12-Oleanene-3,15,16,22,28-pentol

C35H56O6 (572.4077)

pauperol

C36H60O5 (572.4441)

C36H60O5

C36H60O5 (572.4441)

3beta,6beta-diacetoxy-19alpha-hydroxyurs-12-en-18-oic acid

C34H52O7 (572.3713)

butyl ganoderate A

C34H52O7 (572.3713)

C35H56O6

C35H56O6 (572.4077)

7-desmethyldeoxyneofusapyrone

C35H56O6 (572.4077)

3beta,12alpha-diacetoxy-7,8-dihydroholothurinogenin

C34H52O7 (572.3713)

FT-0670683

C40H60O2 (572.4593)

Barringtogenol B|Barringtogenol B; 3beta,21beta,22alpha,28-Tetrahydroxy-16alpha-angeloyloxy-oleanen-(12)|Barrintogenol B

C35H56O6 (572.4077)

Pygmaeic acid

C34H52O7 (572.3713)

3beta-(E)-coumaroyloxy-urs-12-ene

C39H56O3 (572.4229)

22-Dehydroclerosterol glucoside

C35H56O6 (572.4077)

12-Deoxy-4beta-OH-phorbol-13-dodecanoat-20-acetat

C34H52O7 (572.3713)

C30H56N2O8

C30H56N2O8 (572.4036)

23-acetoxy-3beta-O-acetylimberbic acid

C34H52O7 (572.3713)

22-Angeloyl -(3beta,15alpha,16alpha,22alpha)-12-Oleanene-3,15,16,22,28-pentol|Olean-12-en-3beta,15alpha,16alpha,22alpha,28-pentol-22-angelat

C35H56O6 (572.4077)

germanicol trans-coumaroyl ester|olean-18-en-3beta-O-(E)-coumaroyl ester

C39H56O3 (572.4229)

agladoral D

C34H52O7 (572.3713)

stigmasterol d-glucoside

C36H60O5 (572.4441)

2alpha,24?diacetoxy?3beta?hydroxyolean?12?en?28?oic acid

C34H52O7 (572.3713)

(3b,11a,19b)-3-(butanoyloxy)-11-hydroxytaraxast-20(30)-ene-23,28-dioic acid|clerodendrumic acid

C34H52O7 (572.3713)

eleutheroside A

C36H60O5 (572.4441)

feroniellide E

C35H56O6 (572.4077)

RM-T ethyl ester

C34H52O7 (572.3713)

Acutangulinsaeurediacetat

C34H52O7 (572.3713)

2,23-Di-Ac-Asiatic acid

C34H52O7 (572.3713)

3-O-(alpha-L-arabinopyranosyl)-30-norolea-12,20(29)-dien-28-oic acid|3-O--30-norolea-12,20(29)-dien-28-oic acid|3-O--30-norolean-12,20(29)-dien-28-oic acid

C34H52O7 (572.3713)

Milbemycin E

C34H52O7 (572.3713)

tagalsin I

C40H60O2 (572.4593)

honulactone K

C34H52O7 (572.3713)

C34H52O7

C34H52O7 (572.3713)

24beta-ethylcholesta-5,9(11),22E-trien 3-O--beta-D-glucoside|elaeagnoside

C35H56O6 (572.4077)

stigmast-7-en-3beta-ol 3-O-beta-D-glucopyranoside

C35H56O6 (572.4077)

7alpha-n-pentadecanoyloxy-6beta,12-dihydroxy-abieta-8,12-diene-11,14-dione

C35H56O6 (572.4077)

honulactone J

C34H52O7 (572.3713)

drosericarpone

C34H52O7 (572.3713)

Nephilatoxin 8

C29H48N8O4 (572.3798)

Diacetyl-uncaric-saeure

C34H52O7 (572.3713)

(2R,6R)-6-[(3R,10S,12S,13R,17R)-3-(2-carboxyacetyl)oxy-12-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-3-methylideneheptanoic acid

C34H52O7 (572.3713)

(2R,6R)-6-[(3R,10S,12S,13R,17R)-3-(2-carboxyacetyl)oxy-12-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-3-methylideneheptanoic acid [IIN-based: Match]

C34H52O7 (572.3713)

(2R,6R)-6-[(3R,10S,12S,13R,17R)-3-(2-carboxyacetyl)oxy-12-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-3-methylideneheptanoic acid [IIN-based on: CCMSLIB00000845395]

C34H52O7 (572.3713)

(2R,6R)-6-[(3R,10S,12S,13R,17R)-3-(2-carboxyacetyl)oxy-12-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-3-methylideneheptanoic acid [IIN-based on: CCMSLIB00000845398]

C34H52O7 (572.3713)

(2R,6R)-6-[(3R,10S,12S,13R,17R)-3-(2-carboxyacetyl)oxy-12-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-3-methylideneheptanoic acid_major

C34H52O7 (572.3713)

ITVKL

C27H52N6O7 (572.3897)

Dihydroparasiloxanthin/ 7,8,7,8-Tetrahydrozeaxanthin

C40H60O2 (572.4593)

OH-Demethylspheroidene

C40H60O2 (572.4593)

Vitamin D2 glucosiduronate

C34H52O7 (572.3713)

5,6-Dihydro-5,6-dihydroxy-y,y-carotene

C40H60O2 (572.4593)

22-Angeloylbarringtogenol C

C35H56O6 (572.4077)

Ganoderic acid W

C34H52O7 (572.3713)

(3b,5a,22E,24S)-Stigmasta-7,22,25-trien-3-ol 3-glucoside

C35H56O6 (572.4077)

Ganoderic acid Ma

C34H52O7 (572.3713)

7,8-Dihydroparasiloxanthin

C40H60O2 (572.4593)

3'-N-Acetyl-4'-O-(14-methylpentadecanoyl)fusarochromanone

C33H52N2O6 (572.3825)

DG(13:0/20:5(5Z,8Z,11Z,14Z,17Z)/0:0)[iso2]

C36H60O5 (572.4441)

IC202A

C27H52N6O7 (572.3897)

A N-oxide isolated from Streptoalloteichus sp.1454-19. It is a siderophore which exhibits immunosuppressive activity on a mixed lymphocyte culture reaction (MLCR).

DG 33:5

C36H60O5 (572.4441)

Vitamin D2 3-glucuronide

C34H52O7 (572.3713)

D018977 - Micronutrients > D014815 - Vitamins > D004872 - Ergocalciferols

Dihydroparasiloxanthin

C40H60O2 (572.4593)

OH-Rhodopin

C40H60O2 (572.4593)

9,10-Dihydro-beta-zeacarotene-3,17-diol

C40H60O2 (572.4593)

Dihydroxypirardixanthin

C40H60O2 (572.4593)

Tri-tert-butyl 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetate

C28H52N4O8 (572.3785)

azacyclotridecan-2-one,azepan-2-one,hexane-1,6-diamine,hexanedioic acid

C30H60N4O6 (572.4513)

Tetraoctyltin

C32H68Sn (572.4343)

(2Z)-2-(Hydroxymethylene)-3-oxoolean-12-en-28-oic acid phenylmethyl ester

C38H52O4 (572.3865)

POLYOXYETHYLENE(7.5) NONYLPHENYL ETHER

C31H56O9 (572.3924)

[(1S,4S,5R,6R)-6-(hydroxymethyl)-2,5-dimethyl-4-[(1E,3E)-2-methyl-4-(2,6,6-trimethylcyclohexen-1-yl)buta-1,3-dienyl]-5-[(1E,3E,5E)-4-methyl-6-(2,6,6-trimethylcyclohexen-1-yl)hexa-1,3,5-trienyl]cyclohex-2-en-1-yl]methanol

C40H60O2 (572.4593)

2-[4-(dimethylamino)-3-oxo-4H-pyridin-1-ium-1-yl]ethyl (2-ethoxy-3-hexadecoxypropyl) phosphite

C30H57N2O6P (572.3954)

Pancuronium

C35H60N2O4 (572.4553)

Pancuronium is only found in individuals that have used or taken this drug. It is a bis-quaternary steroid that is a competitive nicotinic antagonist. As a neuromuscular blocking agent it is more potent than curare but has less effect on the circulatory system and on histamine release.Nondepolarizing neuromuscular blocking agents inhibit neuromuscular transmission by competing with acetylcholine for the cholinergic receptors of the motor end plate, thereby reducing the response of the end plate to acetylcholine. This type of neuromuscular block is usually antagonized by anticholinesterase agents.

Dihydroparasiloxanthin/7,8,7,8-Tetrahydrozeaxanthin

C40H60O2 (572.4593)

DG(10:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0)

C35H56O6 (572.4077)

DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/10:0/0:0)

C35H56O6 (572.4077)

DG(10:0/0:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4))

C35H56O6 (572.4077)

DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0/10:0)

C35H56O6 (572.4077)

DG(10:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0)

C35H56O6 (572.4077)

DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/10:0/0:0)

C35H56O6 (572.4077)

DG(10:0/0:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7))

C35H56O6 (572.4077)

DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0/10:0)

C35H56O6 (572.4077)

DG(10:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0)

C35H56O6 (572.4077)

DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/10:0/0:0)

C35H56O6 (572.4077)

DG(10:0/0:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14))

C35H56O6 (572.4077)

DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0/10:0)

C35H56O6 (572.4077)

DG(10:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0)

C35H56O6 (572.4077)

DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/10:0/0:0)

C35H56O6 (572.4077)

DG(10:0/0:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17))

C35H56O6 (572.4077)

DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0/10:0)

C35H56O6 (572.4077)

DG(10:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0)

C35H56O6 (572.4077)

DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/10:0/0:0)

C35H56O6 (572.4077)

DG(10:0/0:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17))

C35H56O6 (572.4077)

DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0/10:0)

C35H56O6 (572.4077)

2-[[(2R)-3-[(7Z,10Z,13Z,16Z)-docosa-7,10,13,16-tetraenoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H55NO7P+ (572.3716)

acetic acid [(3S,5S,9S,14S)-17-acetyloxy-10,13-dimethyl-2,16-bis(1-methyl-1-piperidin-1-iumyl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] ester

C35H60N2O4+2 (572.4553)

[(1S,2R,3R,5R,7R,10S,11R,14R,15S)-15-[(3S,5R)-5-[(2S)-3,3-dimethyloxiran-2-yl]-2-hydroxyoxolan-3-yl]-3-hydroxy-2,6,6,10-tetramethyl-7-pentacyclo[12.3.1.01,14.02,11.05,10]octadecanyl] 3-methylbutanoate

C35H56O6 (572.4077)

(3beta,5Z,7E,22E)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-yl-beta-D-glucopyranosiduronic acid

C34H52O7 (572.3713)

(1R,15R,17S)-17-ethyl-6-[(1R,14R,15E)-15-ethylidene-17,18-dimethyl-10,17-diazatetracyclo[12.3.1.03,11.04,9]octadeca-3(11),4,6,8-tetraen-12-yl]-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraene

C39H48N4 (572.3879)

NAOrn 16:4/13:1

C34H56N2O5 (572.4189)

NAOrn 18:5/11:0

C34H56N2O5 (572.4189)

Mgdg O-16:2_6:0

C31H56O9 (572.3924)

Mgdg O-17:2_5:0

C31H56O9 (572.3924)

Mgdg O-19:2_3:0

C31H56O9 (572.3924)

Mgdg O-20:2_2:0

C31H56O9 (572.3924)

Mgdg O-18:2_4:0

C31H56O9 (572.3924)

PE-Cer 15:3;2O/13:0

C30H57N2O6P (572.3954)

PE-Cer 14:3;2O/14:0

C30H57N2O6P (572.3954)

PE-Cer 16:3;2O/12:0

C30H57N2O6P (572.3954)

PE-Cer 15:2;2O/13:1

C30H57N2O6P (572.3954)

PE-Cer 14:2;2O/14:1

C30H57N2O6P (572.3954)

PE-Cer 13:2;2O/15:1

C30H57N2O6P (572.3954)

PE-Cer 12:1;2O/16:2

C30H57N2O6P (572.3954)

PE-Cer 12:0;2O/16:3

C30H57N2O6P (572.3954)

PE-Cer 12:2;2O/16:1

C30H57N2O6P (572.3954)

[(E)-2-[[(9Z,12Z)-hexadeca-9,12-dienoyl]amino]-3-hydroxynon-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H57N2O6P (572.3954)

[(4E,8E,12E)-3-hydroxy-2-(octanoylamino)heptadeca-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H57N2O6P (572.3954)

[(4E,8E,12E)-2-(heptanoylamino)-3-hydroxyoctadeca-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H57N2O6P (572.3954)

[2-[[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]amino]-3-hydroxynonyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H57N2O6P (572.3954)

[(4E,8E,12E)-3-hydroxy-2-(nonanoylamino)hexadeca-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H57N2O6P (572.3954)

[(4E,8E,12E)-2-acetamido-3-hydroxytricosa-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H57N2O6P (572.3954)

[(4E,8E,12E)-2-(butanoylamino)-3-hydroxyhenicosa-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H57N2O6P (572.3954)

[(4E,8E,12E)-3-hydroxy-2-(propanoylamino)docosa-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H57N2O6P (572.3954)

[(4E,8E,12E)-3-hydroxy-2-(pentanoylamino)icosa-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H57N2O6P (572.3954)

[(4E,8E,12E)-2-(hexanoylamino)-3-hydroxynonadeca-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H57N2O6P (572.3954)

[(4E,8E)-3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]dodeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H57N2O6P (572.3954)

[(4E,8E,12E)-2-(decanoylamino)-3-hydroxypentadeca-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H57N2O6P (572.3954)

[(4E,8E,12E)-3-hydroxy-2-(undecanoylamino)tetradeca-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H57N2O6P (572.3954)

[(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoate

C40H60O2 (572.4593)

[(E)-2-[[(9Z,12Z)-heptadeca-9,12-dienoyl]amino]-3-hydroxyoct-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H57N2O6P (572.3954)

(10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z,34Z,37Z)-tetraconta-10,13,16,19,22,25,28,31,34,37-decaenoic acid

C40H60O2 (572.4593)

(1-hydroxy-3-pentadecanoyloxypropan-2-yl) (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate

C36H60O5 (572.4441)

(1-hydroxy-3-tridecanoyloxypropan-2-yl) (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate

C36H60O5 (572.4441)

[1-hydroxy-3-[(Z)-pentadec-9-enoyl]oxypropan-2-yl] (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate

C36H60O5 (572.4441)

(1-hydroxy-3-undecanoyloxypropan-2-yl) (7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoate

C36H60O5 (572.4441)

[1-hydroxy-3-[(Z)-tridec-9-enoyl]oxypropan-2-yl] (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoate

C36H60O5 (572.4441)

[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-hydroxypropyl] (Z)-heptadec-9-enoate

C36H60O5 (572.4441)

[2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-3-hydroxypropyl] (9Z,12Z)-heptadeca-9,12-dienoate

C36H60O5 (572.4441)

(1-hydroxy-3-nonanoyloxypropan-2-yl) (9Z,12Z,15Z,18Z,21Z)-tetracosa-9,12,15,18,21-pentaenoate

C36H60O5 (572.4441)

[1-Carboxy-3-(2-decanoyloxy-3-dodecanoyloxypropoxy)propyl]-trimethylazanium

C32H62NO7+ (572.4526)

[1-Carboxy-3-[2,3-di(undecanoyloxy)propoxy]propyl]-trimethylazanium

C32H62NO7+ (572.4526)

[1-Carboxy-3-(3-decanoyloxy-2-dodecanoyloxypropoxy)propyl]-trimethylazanium

C32H62NO7+ (572.4526)

[(2S)-1-hydroxy-3-tridecanoyloxypropan-2-yl] (5E,8E,11E,14E,17E)-icosa-5,8,11,14,17-pentaenoate

C36H60O5 (572.4441)

[(2S)-1-hydroxy-3-[(E)-pentadec-9-enoyl]oxypropan-2-yl] (6E,9E,12E,15E)-octadeca-6,9,12,15-tetraenoate

C36H60O5 (572.4441)

[(2S)-3-hydroxy-2-tridecanoyloxypropyl] (5E,8E,11E,14E,17E)-icosa-5,8,11,14,17-pentaenoate

C36H60O5 (572.4441)

2-[[2-[(4Z,7Z,10Z,13Z)-docosa-4,7,10,13-tetraenoyl]oxy-3-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H55NO7P+ (572.3716)

[(2S)-1-hydroxy-3-undecanoyloxypropan-2-yl] (7E,10E,13E,16E,19E)-docosa-7,10,13,16,19-pentaenoate

C36H60O5 (572.4441)

[1-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-hydroxypropan-2-yl] (E)-heptadec-7-enoate

C36H60O5 (572.4441)

[(2S)-3-hydroxy-2-[(E)-pentadec-9-enoyl]oxypropyl] (6E,9E,12E,15E)-octadeca-6,9,12,15-tetraenoate

C36H60O5 (572.4441)

[1-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-hydroxypropan-2-yl] heptadecanoate

C36H60O5 (572.4441)

[1-[(4E,7E)-hexadeca-4,7-dienoyl]oxy-3-hydroxypropan-2-yl] (8E,11E,14E)-heptadeca-8,11,14-trienoate

C36H60O5 (572.4441)

[(2S)-3-hydroxy-2-undecanoyloxypropyl] (7E,10E,13E,16E,19E)-docosa-7,10,13,16,19-pentaenoate

C36H60O5 (572.4441)

[1-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxy-3-hydroxypropan-2-yl] (11E,14E)-heptadeca-11,14-dienoate

C36H60O5 (572.4441)

2-[[(2R)-3-[(7E,10E,13E,16E)-docosa-7,10,13,16-tetraenoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H55NO7P+ (572.3716)

[1-Carboxy-3-(3-heptanoyloxy-2-pentadecanoyloxypropoxy)propyl]-trimethylazanium

C32H62NO7+ (572.4526)

2-[[2-butanoyloxy-3-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H55NO7P+ (572.3716)

2-[[3-[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H55NO7P+ (572.3716)

2-[[2-acetyloxy-3-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H55NO7P+ (572.3716)

[3-(3-Acetyloxy-2-icosanoyloxypropoxy)-1-carboxypropyl]-trimethylazanium

C32H62NO7+ (572.4526)

[3-(3-Butanoyloxy-2-octadecanoyloxypropoxy)-1-carboxypropyl]-trimethylazanium

C32H62NO7+ (572.4526)

[1-Carboxy-3-(3-octanoyloxy-2-tetradecanoyloxypropoxy)propyl]-trimethylazanium

C32H62NO7+ (572.4526)

[1-Carboxy-3-(3-nonanoyloxy-2-tridecanoyloxypropoxy)propyl]-trimethylazanium

C32H62NO7+ (572.4526)

[1-Carboxy-3-(2-nonadecanoyloxy-3-propanoyloxypropoxy)propyl]-trimethylazanium

C32H62NO7+ (572.4526)

[1-Carboxy-3-(2-heptadecanoyloxy-3-pentanoyloxypropoxy)propyl]-trimethylazanium

C32H62NO7+ (572.4526)

[1-Carboxy-3-(2-hexadecanoyloxy-3-hexanoyloxypropoxy)propyl]-trimethylazanium

C32H62NO7+ (572.4526)

2-[carboxy-[3-[(Z)-docos-13-enoyl]oxy-2-hydroxypropoxy]methoxy]ethyl-trimethylazanium

C32H62NO7+ (572.4526)

2-[[3-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoxy]-2-hexanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H55NO7P+ (572.3716)

2-[carboxy-[3-octanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropoxy]methoxy]ethyl-trimethylazanium

C31H58NO8+ (572.4162)

Pancuronium

C35H60N2O4+2 (572.4553)

D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents > D009466 - Neuromuscular Blocking Agents M - Musculo-skeletal system > M03 - Muscle relaxants > M03A - Muscle relaxants, peripherally acting agents D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists C78281 - Agent Affecting Musculoskeletal System > C29696 - Muscle Relaxant

1,1-Dihydroxy-1,1,2,2-tetrahydrolycopene

C40H60O2 (572.4593)

3-N-Acetyl-4-O-(14-methylpentadecanoyl)fusarochromanone

C33H52N2O6 (572.3825)

skimmiarepin A

C35H56O6 (572.4077)

A natural product found in Aegle marmelos.

N-(5-aminopentyl)-N-(5-{[4-({5-[butylidene(oxido)-lambda(5)-azanyl]pentyl}amino)-4-oxobutanoyl](hydroxy)amino}pentyl)-N-hydroxybutanediamide

C27H52N6O7 (572.3897)

1-tridecanoyl-2-(5Z,8Z,11Z,14Z,17Z-eicosapentaenoyl)-sn-glycerol

C36H60O5 (572.4441)

TG(33:5)

C36H60O5 (572.4441)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

NA-Orn 29:5

C34H56N2O5 (572.4189)

FAHFA 12:4/O-26:7

C38H52O4 (572.3865)

FAHFA 13:4/O-25:7

C38H52O4 (572.3865)

FAHFA 14:4/O-24:7

C38H52O4 (572.3865)

FAHFA 15:4/O-23:7

C38H52O4 (572.3865)

FAHFA 15:5/O-23:6

C38H52O4 (572.3865)

FAHFA 16:4/O-22:7

C38H52O4 (572.3865)

FAHFA 16:5/O-22:6

C38H52O4 (572.3865)

FAHFA 17:4/O-21:7

C38H52O4 (572.3865)

FAHFA 17:5/O-21:6

C38H52O4 (572.3865)

FAHFA 18:5/O-20:6

C38H52O4 (572.3865)

FAHFA 18:6/O-20:5

C38H52O4 (572.3865)

FAHFA 19:5/O-19:6

C38H52O4 (572.3865)

FAHFA 19:6/O-19:5

C38H52O4 (572.3865)

FAHFA 20:5/O-18:6

C38H52O4 (572.3865)

FAHFA 20:6/O-18:5

C38H52O4 (572.3865)

FAHFA 21:6/O-17:5

C38H52O4 (572.3865)

FAHFA 21:7/O-17:4

C38H52O4 (572.3865)

FAHFA 22:6/O-16:5

C38H52O4 (572.3865)

FAHFA 22:7/O-16:4

C38H52O4 (572.3865)

FAHFA 23:6/O-15:5

C38H52O4 (572.3865)

FAHFA 23:7/O-15:4

C38H52O4 (572.3865)

FAHFA 24:7/O-14:4

C38H52O4 (572.3865)

FAHFA 25:7/O-13:4

C38H52O4 (572.3865)

FAHFA 26:7/O-12:4

C38H52O4 (572.3865)

DG 11:0_22:5

C36H60O5 (572.4441)

DG 13:0_20:5

C36H60O5 (572.4441)

DG 15:1_18:4

C36H60O5 (572.4441)

MGDG O-22:2

C31H56O9 (572.3924)

MGMG 22:2

C31H56O9 (572.3924)

TG 4:0/10:4/18:1

C35H56O6 (572.4077)

TG 6:0/10:4/16:1

C35H56O6 (572.4077)

LPEth 26:3

C31H57O7P (572.3842)

LPM 27:3

C31H57O7P (572.3842)

CerPE 12:0;O2/16:3

C30H57N2O6P (572.3954)

CerPE 14:2;O2/14:1

C30H57N2O6P (572.3954)

CerPE 28:3;O2

C30H57N2O6P (572.3954)

ST 28:3;O;GlcA

C34H52O7 (572.3713)

ST 28:4;O2;Hex

C34H52O7 (572.3713)

ST 29:3;O;Hex

C35H56O6 (572.4077)

CAE 11:2

C35H56O6 (572.4077)

DCAE 12:1

C36H60O5 (572.4441)

(1r,2r,4as,6as,6br,8r,8ar,10s,12ar,12br,14bs)-8,10-bis(acetyloxy)-1-hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C34H52O7 (572.3713)

(3s,4ar,6ar,6bs,8ar,12ar,14ar,14br)-4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl (2z)-3-(4-hydroxyphenyl)prop-2-enoate

C39H56O3 (572.4229)

1,6-dihydroxy-8-(hydroxymethyl)-4,12,12,15-tetramethyl-5-oxotetracyclo[8.5.0.0²,⁶.0¹¹,¹³]pentadeca-3,8-dien-13-yl pentadecanoate

C35H56O6 (572.4077)

(2e,6r)-6-[(1r,3s,3ar,4r,5ar,7s,9as,11ar)-3,7-bis(acetyloxy)-4-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-methylhept-2-enoic acid

C34H52O7 (572.3713)

[13-(butanoyloxy)-1,6-dihydroxy-4,12,12,15-tetramethyl-5-oxotetracyclo[8.5.0.0²,⁶.0¹¹,¹³]pentadeca-3,8-dien-8-yl]methyl decanoate

C34H52O7 (572.3713)

n-{5-[(3-{[5-({3-[(5-aminopentyl)(hydroxy)carbamoyl]-1-hydroxypropylidene}amino)pentyl](hydroxy)carbamoyl}-1-hydroxypropylidene)amino]pentyl}butanimine oxide

C27H52N6O7 (572.3897)

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,3e,5s)-5-ethyl-6-methylhepta-3,6-dien-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H56O6 (572.4077)

1,1'-dihydroxylycopene

C40H60O2 (572.4593)

(3r,4ar,6ar,8ar,12ar,12bs,14ar,14br)-4,4,6a,8a,11,11,12b,14b-octamethyl-1,2,3,4a,5,6,8,9,10,12,12a,13,14,14a-tetradecahydropicen-3-yl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

C39H56O3 (572.4229)

2-[(1s,2s,3s,5s)-2,3-dihydroxy-5-(hydroxymethyl)cyclohexyl]-3-hydroxy-5-[(2s,3s,4e,6e,8r,9z,12s)-3-hydroxy-6,8,10,12-tetramethyloctadeca-4,6,9-trien-2-yl]cyclohexa-2,4-dien-1-one

C35H56O6 (572.4077)

5-(acetyloxy)-6-[7-(acetyloxy)-4-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-methylhept-2-enoic acid

C34H52O7 (572.3713)

(1s,2s,3s)-3-[(1e,3e,5e,7e,9e,11e,13e,15e,17e)-18-[(1r,5s,6s)-5-hydroxy-2,2,6-trimethylcyclohexyl]-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl]-2,4,4-trimethylcyclohexan-1-ol

C40H60O2 (572.4593)

(3s,4ar,6ar,8ar,12ar,12bs,14ar,14br)-4,4,6a,8a,11,11,12b,14b-octamethyl-1,2,3,4a,5,6,8,9,10,12,12a,13,14,14a-tetradecahydropicen-3-yl (2z)-3-(4-hydroxyphenyl)prop-2-enoate

C39H56O3 (572.4229)

8,10-bis(acetyloxy)-14b-hydroxy-1,4a,6a,6b,9,9,12a-heptamethyl-1,2,3,4,5,6,7,8,8a,10,11,12,12b,13-tetradecahydropicene-2-carboxylic acid

C34H52O7 (572.3713)

(1s,2r,3r,5s,7s,10s,11r,14r,15s)-15-[(2r,3s,5r)-5-[(2s)-3,3-dimethyloxiran-2-yl]-2-hydroxyoxolan-3-yl]-3-hydroxy-2,6,6,10-tetramethylpentacyclo[12.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecan-7-yl 3-methylbutanoate

C35H56O6 (572.4077)

(4as,9s,10s,10as)-6,10-dihydroxy-7-isopropyl-1,1,4a-trimethyl-5,8-dioxo-2,3,4,9,10,10a-hexahydrophenanthren-9-yl pentadecanoate

C35H56O6 (572.4077)

(1r)-4-[(3e,5e,7e,9e,11e,13e,15e)-18-[(4r)-4-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl]-3,7,12,16-tetramethyloctadeca-3,5,7,9,11,13,15-heptaen-1-yl]-3,5,5-trimethylcyclohex-3-en-1-ol

C40H60O2 (572.4593)

{3-[(16r,17r)-16,17-dihydroxypentacosyl]-5-hydroxyphenyl}oxidanesulfonic acid

C31H56O7S (572.3747)

[3-(16,17-dihydroxypentacosyl)-5-hydroxyphenyl]oxidanesulfonic acid

C31H56O7S (572.3747)

22-o-angeloyl theasapogenol b

C35H56O6 (572.4077)

{"Ingredient_id": "HBIN003746","Ingredient_name": "22-o-angeloyl theasapogenol b","Alias": "NA","Ingredient_formula": "C35H56O6","Ingredient_Smile": "CC=C(C)C(=O)OC1C(C(CC2C1(C(CC3(C2=CCC4C3(CCC5C4(CCC(C5(C)C)O)C)C)C)O)CO)(C)C)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1236","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

3-o-(e)-coumaroyl-β-amyrin

C39H56O3 (572.4229)

{"Ingredient_id": "HBIN009318","Ingredient_name": "3-o-(e)-coumaroyl-\u03b2-amyrin","Alias": "NA","Ingredient_formula": "C39H56O3","Ingredient_Smile": "CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)OC(=O)C=CC6=CC=C(C=C6)O)C)C)C2C1)C)C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4149","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

3-o-(z)-coumaroyl-β-amyrin

C39H56O3 (572.4229)

{"Ingredient_id": "HBIN009443","Ingredient_name": "3-o-(z)-coumaroyl-\u03b2-amyrin","Alias": "NA","Ingredient_formula": "C39H56O3","Ingredient_Smile": "CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)OC(=O)C=CC6=CC=C(C=C6)O)C)C)C2C1)C)C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4150","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

3-(z)-coumaroyllupeol

C39H56O3 (572.4229)

{"Ingredient_id": "HBIN009770","Ingredient_name": "3-(z)-coumaroyllupeol","Alias": "NA","Ingredient_formula": "C39H56O3","Ingredient_Smile": "CC(=C)C1CCC2(C1C3CCC4C5(CCC(C(C5CCC4(C3(CC2)C)C)(C)C)OC(=O)C=CC6=CC=C(C=C6)O)C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4168","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

methyl (2e)-5-[(1s,4ar,5r,8ar)-5-({[(3s)-5-[(1r,2r)-2-hydroxy-2,6,6-trimethylcyclohexyl]-3-methylpentanoyl]oxy}methyl)-5,8a-dimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]-3-methylpent-2-enoate

C36H60O5 (572.4441)

(1r,4ar,4bs,4'bs,6'as,7s,8's,8as,10as,10'as,10'br)-7,8'-diethenyl-4b,4'b,7,8',10a,10'a-hexamethyl-4,4',4a,5,5',6,6',6'a,7',8,8a,9,9',10,10',10'b,11',12'-octadecahydro-3h,3'h-spiro[phenanthrene-1,2'-phenanthro[2,1-b]pyran]-2-one

C40H60O2 (572.4593)

(2e,6r)-6-[(1r,3s,3ar,4r,7s,9as,11ar)-3,7-bis(acetyloxy)-4-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-methylhept-2-enoic acid

C34H52O7 (572.3713)

(6e,8e,10e,12z,14e,16e,18e,20e,22e,24e,26e)-2,6,10,14,19,23,27,31-octamethyldotriaconta-6,8,10,12,14,16,18,20,22,24,26-undecaene-2,31-diol

C40H60O2 (572.4593)

7,8'-diethenyl-4b,4'b,7,8',10a,10'a-hexamethyl-4,4',4a,5,5',6,6',6'a,7',8,8a,9,9',10,10',10'b,11',12'-octadecahydro-3h,3'h-spiro[phenanthrene-1,2'-phenanthro[2,1-b]pyran]-2-one

C40H60O2 (572.4593)

(1r,3ar,5ar,5br,7ar,9s,11ar,11br,13ar,13br)-3a,5a,5b,8,8,11a-hexamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

C39H56O3 (572.4229)

(1s,4s,5r,6s,9r,10r,12r,14r)-4,5,6-trihydroxy-3,11,11,14-tetramethyl-15-oxotetracyclo[7.5.1.0¹,⁵.0¹⁰,¹²]pentadeca-2,7-dien-7-yl hexadecanoate

C35H56O6 (572.4077)

2,3,5-trihydroxy-4-{[(4e)-13-hydroxy-2,4,6,8-tetramethyl-3-oxodocos-4-enoyl]oxy}pentanoic acid

C31H56O9 (572.3924)

(3s,4ar,6ar,6bs,8ar,12as,14ar,14br)-4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl (2z)-3-(4-hydroxyphenyl)prop-2-enoate

C39H56O3 (572.4229)

4-[18-(4-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl)-3,7,12,16-tetramethyloctadeca-3,5,7,9,11,13,15-heptaen-1-yl]-3,5,5-trimethylcyclohex-3-en-1-ol

C40H60O2 (572.4593)

(3s,4ar,6ar,6br,8ar,12bs,14ar,14br)-4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12b,13,14,14a-tetradecahydropicen-3-yl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

C39H56O3 (572.4229)

(2e,6r)-6-[(1r,3s,3ar,4r,5ar,7s,9as,11ar)-4,7-bis(acetyloxy)-3-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-methylhept-2-enoic acid

C34H52O7 (572.3713)

butyl 6-{4,7-dihydroxy-3a,6,6,9a,11a-pentamethyl-3,10-dioxo-1h,2h,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl}-2-methyl-4-oxoheptanoate

C34H52O7 (572.3713)

2-[2,3-dihydroxy-5-(hydroxymethyl)cyclohexyl]-3-hydroxy-5-(3-hydroxy-6,8,10,12-tetramethyloctadeca-4,6,9-trien-2-yl)cyclohexa-2,4-dien-1-one

C35H56O6 (572.4077)

(4s,4ar,5s,6r,6as,6br,8ar,10s,12ar,12br,14bs)-5,6,10-trihydroxy-4a-(hydroxymethyl)-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicen-4-yl 3-methylbut-2-enoate

C35H56O6 (572.4077)

butyl (6r)-6-[(1r,3s,3ar,4s,5ar,9as,11ar)-3,4-dihydroxy-3a,6,6,9a,11a-pentamethyl-7,10-dioxo-1h,2h,3h,4h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoate

C34H52O7 (572.3713)

(4s,4ar,5s,6r,6as,6br,8ar,10s,12ar,12br,14bs)-5,6,10-trihydroxy-4a-(hydroxymethyl)-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicen-4-yl (2e)-2-methylbut-2-enoate

C35H56O6 (572.4077)

6-[3,7-bis(acetyloxy)-4-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-methylhept-2-enoic acid

C34H52O7 (572.3713)

4,4,6a,6b,8a,11,12,14b-octamethyl-2,3,4a,5,6,7,8,9,10,11,12,12a,14,14a-tetradecahydro-1h-picen-3-yl 3-(4-hydroxyphenyl)prop-2-enoate

C39H56O3 (572.4229)

(3r,4ar,6ar,8ar,12ar,12bs,14ar,14br)-4,4,6a,8a,11,11,12b,14b-octamethyl-1,2,3,4a,5,6,8,9,10,12,12a,13,14,14a-tetradecahydropicen-3-yl 3-(4-hydroxyphenyl)prop-2-enoate

C39H56O3 (572.4229)

(3r,5as,5br,7ar,8s,11ar,11br,13s,13as)-3,5b,8,11a,13a-pentamethyl-1-oxo-8-[1-(propanoyloxy)ethyl]-3h,4h,5h,5ah,6h,7h,7ah,9h,10h,11h,11bh,12h,13h-chryseno[1,2-c]furan-13-yl 3-hydroxybutanoate

C34H52O7 (572.3713)

(2e,6s)-6-[(1r,3s,3ar,4r,5ar,7s,9as,11ar)-3,7-bis(acetyloxy)-4-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-methylhept-2-enoic acid

C34H52O7 (572.3713)

6-{7-[(2-carboxyacetyl)oxy]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl}-2,3-dimethyl-4-oxoheptanoic acid

C34H52O7 (572.3713)

(z)-{5-[(3-{[5-({3-[(5-aminopentyl)(hydroxy)carbamoyl]-1-hydroxypropylidene}amino)pentyl](hydroxy)carbamoyl}-1-hydroxypropylidene)amino]pentyl}(butylidene)oxidoazanium

C27H52N6O7 (572.3897)

(3s,5as,5br,7ar,8s,11ar,11br,13s,13as)-8-[1-(acetyloxy)ethyl]-3,5b,8,11a,13a-pentamethyl-1-oxo-3h,4h,5h,5ah,6h,7h,7ah,9h,10h,11h,11bh,12h,13h-chryseno[1,2-c]furan-13-yl 3-hydroxypentanoate

C34H52O7 (572.3713)

2-{[1-(5-ethyl-6-methylhepta-3,6-dien-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H56O6 (572.4077)

(2r,3r,4s,5s,6r)-2-{[(1r,3ar,7s,9ar,9bs,11ar)-1-[(2r,3e,5s)-5-ethyl-6-methylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H56O6 (572.4077)

4,4,6a,8a,11,11,12b,14b-octamethyl-1,2,3,4a,5,6,8,9,10,12,12a,13,14,14a-tetradecahydropicen-3-yl 3-(4-hydroxyphenyl)prop-2-enoate

C39H56O3 (572.4229)

(3r,4r,4ar,5r,6as,6br,8ar,10s,12ar,12br,14bs)-4,5,10-trihydroxy-4a-(hydroxymethyl)-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicen-3-yl (2z)-2-methylbut-2-enoate

C35H56O6 (572.4077)

[(1r,2s,6r,10s,11r,13s,15r)-13-(butanoyloxy)-1,6-dihydroxy-4,12,12,15-tetramethyl-5-oxotetracyclo[8.5.0.0²,⁶.0¹¹,¹³]pentadeca-3,8-dien-8-yl]methyl decanoate

C34H52O7 (572.3713)

(1s,2s,3s)-3-[(1e,3e,5e,7e,9e,11e,13e,15e,17e)-18-[(1s,5s,6s)-5-hydroxy-2,2,6-trimethylcyclohexyl]-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl]-2,4,4-trimethylcyclohexan-1-ol

C40H60O2 (572.4593)

(2e,4e)-5-[(2r,3s,6s,8r,9s)-3-butyl-8-[(2e,4e,6s,7s,8e)-10-ethoxy-6-hydroxy-3,7-dimethyl-10-oxodeca-2,4,8-trien-1-yl]-9-methyl-1,7-dioxaspiro[5.5]undecan-2-yl]-3-methylpenta-2,4-dienoic acid

C34H52O7 (572.3713)

6-{7-[(2-carboxyacetyl)oxy]-11-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl}-2-methyl-3-methylideneheptanoic acid

C34H52O7 (572.3713)

6a,6b,9,9,12a-pentamethyl-2-methylidene-10-[(3,4,5-trihydroxyoxan-2-yl)oxy]-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C34H52O7 (572.3713)

2-{3-hydroxy-7-[(2-methoxy-2-oxoacetyl)oxy]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl}-6-methyl-5-methylideneheptanoic acid

C34H52O7 (572.3713)

(2s,6r)-6-[(1r,3as,5ar,7r,9as,11s,11ar)-7-[(2-carboxyacetyl)oxy]-11-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-3-methylideneheptanoic acid

C34H52O7 (572.3713)

1-(4-{3a,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,3h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}-5-(acetyloxy)oxolan-2-yl)-2-hydroxy-2-methylpropyl acetate

C34H52O7 (572.3713)

n-[1-({4,5-dihydroxy-3-[(1-hydroxybutylidene)amino]-6-(hydroxymethyl)oxan-2-yl}oxy)-3-methyl-1-oxobutan-2-yl]pentadecanimidic acid

C30H56N2O8 (572.4036)

(1s,2r,3r,5r,7r,10s,11r,14r,15s)-3-hydroxy-15-[(3s,5r,6r)-5-hydroxy-6-(2-hydroxypropan-2-yl)oxan-3-yl]-2,6,6,10-tetramethylpentacyclo[12.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecan-7-yl 3-methylbut-2-enoate

C35H56O6 (572.4077)

(2e,6r)-6-[(1r,3s,3ar,4r,5ar,7r,9as,11ar)-4,7-bis(acetyloxy)-3-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-methylhept-2-enoic acid

C34H52O7 (572.3713)

8,10-bis(acetyloxy)-1-hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C34H52O7 (572.3713)

(3s,4ar,6ar,6bs,8ar,11r,12s,12ar,14ar,14br)-4,4,6a,6b,8a,11,12,14b-octamethyl-2,3,4a,5,6,7,8,9,10,11,12,12a,14,14a-tetradecahydro-1h-picen-3-yl (2z)-3-(4-hydroxyphenyl)prop-2-enoate

C39H56O3 (572.4229)

[(2s,10r,11r,12r,15r)-10-(acetyloxy)-15-[(2z)-6-hydroxy-6-methylhept-2-en-2-yl]-7,7,11,12-tetramethyl-5-oxo-6-oxatetracyclo[9.7.0.0²,⁸.0¹²,¹⁶]octadec-8-en-2-yl]methyl acetate

C34H52O7 (572.3713)

(2r,4as,6as,6br,8ar,9r,10s,12s,12ar,12bs,14bs)-10-(acetyloxy)-9-[(acetyloxy)methyl]-12-hydroxy-2,4a,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-2-carboxylic acid

C34H52O7 (572.3713)

2-{[1-(5-ethyl-6-methylhept-3-en-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H56O6 (572.4077)

methyl 5-[5-({[5-(2-hydroxy-2,6,6-trimethylcyclohexyl)-3-methylpentanoyl]oxy}methyl)-5,8a-dimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]-3-methylpent-2-enoate

C36H60O5 (572.4441)

(1s,2r,4ar,6as,6br,8r,8ar,10s,12ar,12br,14bs)-8,10-bis(acetyloxy)-14b-hydroxy-1,4a,6a,6b,9,9,12a-heptamethyl-1,2,3,4,5,6,7,8,8a,10,11,12,12b,13-tetradecahydropicene-2-carboxylic acid

C34H52O7 (572.3713)

4,5,10-trihydroxy-4a-(hydroxymethyl)-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicen-3-yl 2-methylbut-2-enoate

C35H56O6 (572.4077)

(2r,3r,6r)-6-[(1r,3ar,5ar,7r,9as,11ar)-7-[(2-carboxyacetyl)oxy]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-2,3-dimethyl-4-oxoheptanoic acid

C34H52O7 (572.3713)

butyl (2r,6r)-6-[(1r,3s,3ar,4s,5ar,9as,11ar)-3,4-dihydroxy-3a,6,6,9a,11a-pentamethyl-7,10-dioxo-1h,2h,3h,4h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoate

C34H52O7 (572.3713)

(2e,6r)-6-[(1r,3s,3ar,4r,5as,7s,9as,11ar)-3,7-bis(acetyloxy)-4-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-methylhept-2-enoic acid

C34H52O7 (572.3713)

butyl (2r,6r)-6-[(1r,3ar,4s,5ar,7s,9as,11ar)-4,7-dihydroxy-3a,6,6,9a,11a-pentamethyl-3,10-dioxo-1h,2h,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoate

C34H52O7 (572.3713)

(1s,2r,3r,5r,7r,10s,11r,14r,15s)-15-[(2r,3s,5r)-5-[(2s)-3,3-dimethyloxiran-2-yl]-2-hydroxyoxolan-3-yl]-3-hydroxy-2,6,6,10-tetramethylpentacyclo[12.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecan-7-yl 3-methylbutanoate

C35H56O6 (572.4077)

5-(acetyloxy)-6-[3-(acetyloxy)-7-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-methylhept-2-enoic acid

C34H52O7 (572.3713)

(2e,5s,6s)-6-[(1r,3s,3ar,5ar,7s,9as,11ar)-3-(acetyloxy)-7-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-5-(acetyloxy)-2-methylhept-2-enoic acid

C34H52O7 (572.3713)

(2e,6r)-6-[(1r,3s,3ar,4r,5ar,7r,9as,11ar)-3,7-bis(acetyloxy)-4-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-methylhept-2-enoic acid

C34H52O7 (572.3713)

4-(acetyloxy)-3-[(acetyloxy)methylidene]-7,11-dimethyldodeca-6,10-dien-8-yn-1-yl hexadecanoate

C35H56O6 (572.4077)

(1's,2r,4'r,5s,6r,7's,9's,10'e,12'e,14'r,16'z,19'r)-9'-hydroxy-10'-(hydroxymethyl)-6-isopropyl-7'-methoxy-5,6',14',16'-tetramethyl-2',20'-dioxaspiro[oxane-2,21'-tricyclo[17.3.1.0⁴,⁹]tricosane]-5',10',12',16'-tetraen-3'-one

C34H52O7 (572.3713)

(1r,3ar,5ar,5br,7ar,9s,11ar,11br,13ar,13br)-3a,5a,5b,8,8,11a-hexamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl (2z)-3-(4-hydroxyphenyl)prop-2-enoate

C39H56O3 (572.4229)

(4as,6as,6br,8ar,10s,12ar,12br,14bs)-6a,6b,9,9,12a-pentamethyl-2-methylidene-10-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C34H52O7 (572.3713)

4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl 3-(4-hydroxyphenyl)prop-2-enoate

C39H56O3 (572.4229)

(2r,3s,6r)-6-[(1r,3ar,5ar,7r,9as,11ar)-7-[(2-carboxyacetyl)oxy]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-2,3-dimethyl-4-oxoheptanoic acid

C34H52O7 (572.3713)

5,6,10-trihydroxy-4a-(hydroxymethyl)-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicen-4-yl 3-methylbut-2-enoate

C35H56O6 (572.4077)

(2r)-2-[(1r,3s,3ar,5ar,7s,9as,11ar)-3-hydroxy-7-[(2-methoxy-2-oxoacetyl)oxy]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-6-methyl-5-methylideneheptanoic acid

C34H52O7 (572.3713)

(2e,6s)-6-[(1r,3s,3ar,4r,5ar,7s,9as,11ar)-4,7-bis(acetyloxy)-3-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-methylhept-2-enoic acid

C34H52O7 (572.3713)

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,3e,5r)-5-ethyl-6-methylhepta-3,6-dien-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H56O6 (572.4077)

(3s,4ar,6ar,6bs,8ar,11r,12s,12ar,14ar,14br)-4,4,6a,6b,8a,11,12,14b-octamethyl-2,3,4a,5,6,7,8,9,10,11,12,12a,14,14a-tetradecahydro-1h-picen-3-yl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

C39H56O3 (572.4229)

4-[(3e,5e,7e,9e,11e,13e)-18-(4-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl)-3,7,12,16-tetramethyloctadeca-3,5,7,9,11,13,15-heptaen-1-yl]-3,5,5-trimethylcyclohex-3-en-1-ol

C40H60O2 (572.4593)

(4s,4ar,5s,6r,6as,6br,8ar,10s,12ar,12br,14bs)-5,6,10-trihydroxy-4a-(hydroxymethyl)-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicen-4-yl (2z)-2-methylbut-2-enoate

C35H56O6 (572.4077)

(3s,5as,5br,7ar,8s,11ar,11br,13s,13as)-3,5b,8,11a,13a-pentamethyl-1-oxo-8-[1-(propanoyloxy)ethyl]-3h,4h,5h,5ah,6h,7h,7ah,9h,10h,11h,11bh,12h,13h-chryseno[1,2-c]furan-13-yl 3-hydroxybutanoate

C34H52O7 (572.3713)

(2e,5s,6s)-6-[(1r,3ar,4r,5ar,7s,9as,11ar)-7-(acetyloxy)-4-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-5-(acetyloxy)-2-methylhept-2-enoic acid

C34H52O7 (572.3713)

6,10-dihydroxy-7-isopropyl-1,1,4a-trimethyl-5,8-dioxo-2,3,4,9,10,10a-hexahydrophenanthren-9-yl pentadecanoate

C35H56O6 (572.4077)

(1r,3s,3ar,5ar,5bs,7as,9s,11r,11as,11br,13ar,13br)-9,11-bis(acetyloxy)-3-hydroxy-3a,5a,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysene-5b-carboxylic acid

C34H52O7 (572.3713)

(1r,3ar,5ar,5br,7ar,9r,11ar,11br,13ar,13br)-3a,5a,5b,8,8,11a-hexamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl (2z)-3-(4-hydroxyphenyl)prop-2-enoate

C39H56O3 (572.4229)

(1r,3ar,5ar,5br,7ar,9r,11as,11br,13ar,13bs)-3a,5a,5b,8,8,11a-hexamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl (2z)-3-(4-hydroxyphenyl)prop-2-enoate

C39H56O3 (572.4229)

(1r,2s,6r,10s,11r,13s,15r)-1,6-dihydroxy-8-(hydroxymethyl)-4,12,12,15-tetramethyl-5-oxotetracyclo[8.5.0.0²,⁶.0¹¹,¹³]pentadeca-3,8-dien-13-yl pentadecanoate

C35H56O6 (572.4077)

2,3,5-trihydroxy-4-[(13-hydroxy-2,4,6,8-tetramethyl-3-oxodocos-4-enoyl)oxy]pentanoic acid

C31H56O9 (572.3924)

(1s,2r,3r,5r,7s,10s,11r,14r,15s)-15-[(3s,5r)-5-[(2s)-3,3-dimethyloxiran-2-yl]-2-hydroxyoxolan-3-yl]-3-hydroxy-2,6,6,10-tetramethylpentacyclo[12.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecan-7-yl 3-methylbutanoate

C35H56O6 (572.4077)

n-(1-{[(2r,3r,4r,5s,6r)-4,5-dihydroxy-3-[(1-hydroxybutylidene)amino]-6-(hydroxymethyl)oxan-2-yl]oxy}-3-methyl-1-oxobutan-2-yl)pentadecanimidic acid

C30H56N2O8 (572.4036)

[(1r,2s,10r,11r,12r,15r,16r)-10-(acetyloxy)-15-[(2z)-6-hydroxy-6-methylhept-2-en-2-yl]-7,7,11,12-tetramethyl-5-oxo-6-oxatetracyclo[9.7.0.0²,⁸.0¹²,¹⁶]octadec-8-en-2-yl]methyl acetate

C34H52O7 (572.3713)

(1r)-1-[(2s,4s,5s)-4-[(1s,3as,5ar,9ar,9br,11as)-3a,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,3h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-5-(acetyloxy)oxolan-2-yl]-2-hydroxy-2-methylpropyl acetate

C34H52O7 (572.3713)

(1s,3r,6r,8s,11r,12s,15r,16r)-7,7,12,16-tetramethyl-15-[(2r)-6-methylhept-5-en-2-yl]pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

C39H56O3 (572.4229)

15-[5-(3,3-dimethyloxiran-2-yl)-2-hydroxyoxolan-3-yl]-3-hydroxy-2,6,6,10-tetramethylpentacyclo[12.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecan-7-yl 3-methylbutanoate

C35H56O6 (572.4077)

4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12b,13,14,14a-tetradecahydropicen-3-yl 3-(4-hydroxyphenyl)prop-2-enoate

C39H56O3 (572.4229)

(3r,6r)-6-[(1r,3ar,5ar,7r,9as,11ar)-7-[(2-carboxyacetyl)oxy]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-2,3-dimethyl-4-oxoheptanoic acid

C34H52O7 (572.3713)

[10-(acetyloxy)-15-(6-hydroxy-6-methylhept-2-en-2-yl)-7,7,11,12-tetramethyl-5-oxo-6-oxatetracyclo[9.7.0.0²,⁸.0¹²,¹⁶]octadec-8-en-2-yl]methyl acetate

C34H52O7 (572.3713)

butyl 6-{3,4-dihydroxy-3a,6,6,9a,11a-pentamethyl-7,10-dioxo-1h,2h,3h,4h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl}-2-methyl-4-oxoheptanoate

C34H52O7 (572.3713)

3-hydroxy-15-[5-hydroxy-6-(2-hydroxypropan-2-yl)oxan-3-yl]-2,6,6,10-tetramethylpentacyclo[12.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecan-7-yl 3-methylbut-2-enoate

C35H56O6 (572.4077)

6-[4,7-bis(acetyloxy)-3-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-methylhept-2-enoic acid

C34H52O7 (572.3713)

(3s,4ar,6ar,6br,8ar,12bs,14ar,14br)-4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12b,13,14,14a-tetradecahydropicen-3-yl (2z)-3-(4-hydroxyphenyl)prop-2-enoate

C39H56O3 (572.4229)

9,11-bis(acetyloxy)-3-hydroxy-3a,5a,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysene-5b-carboxylic acid

C34H52O7 (572.3713)

(1s,2r,3r,5r,7s,10s,11r,14r,15s)-15-[(2r,3s,5r)-5-[(2s)-3,3-dimethyloxiran-2-yl]-2-hydroxyoxolan-3-yl]-3-hydroxy-2,6,6,10-tetramethylpentacyclo[12.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecan-7-yl 3-methylbutanoate

C35H56O6 (572.4077)

(3z,4s,6e)-4-(acetyloxy)-3-[(acetyloxy)methylidene]-7,11-dimethyldodeca-6,10-dien-8-yn-1-yl hexadecanoate

C35H56O6 (572.4077)

7,7,12,16-tetramethyl-15-(6-methylhept-5-en-2-yl)pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl 3-(4-hydroxyphenyl)prop-2-enoate

C39H56O3 (572.4229)

(3s,4ar,6ar,8ar,12ar,12bs,14ar,14br)-4,4,6a,8a,11,11,12b,14b-octamethyl-1,2,3,4a,5,6,8,9,10,12,12a,13,14,14a-tetradecahydropicen-3-yl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

C39H56O3 (572.4229)

(3r,4ar,6ar,8ar,12ar,12bs,14ar,14br)-4,4,6a,8a,11,11,12b,14b-octamethyl-1,2,3,4a,5,6,8,9,10,12,12a,13,14,14a-tetradecahydropicen-3-yl (2z)-3-(4-hydroxyphenyl)prop-2-enoate

C39H56O3 (572.4229)

5,6,10-trihydroxy-4a-(hydroxymethyl)-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicen-4-yl 2-methylbut-2-enoate

C35H56O6 (572.4077)

(1s)-4-[(3z,5e,7e,9e,11e,13e,15e)-18-[(4s)-4-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl]-3,7,12,16-tetramethyloctadeca-3,5,7,9,11,13,15-heptaen-1-yl]-3,5,5-trimethylcyclohex-3-en-1-ol

C40H60O2 (572.4593)

(2r,3r,4s,5s,6r)-2-{[(1r,3ar,7s,9ar,9bs,11ar)-1-[(2r,3e,5r)-5-ethyl-6-methylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H56O6 (572.4077)

(3r,5as,5br,7ar,8s,11ar,11br,13s,13as)-8-[1-(acetyloxy)ethyl]-3,5b,8,11a,13a-pentamethyl-1-oxo-3h,4h,5h,5ah,6h,7h,7ah,9h,10h,11h,11bh,12h,13h-chryseno[1,2-c]furan-13-yl 3-hydroxypentanoate

C34H52O7 (572.3713)

(3s,4ar,6ar,6bs,8ar,12ar,14ar,14br)-4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

C39H56O3 (572.4229)

(1r,3ar,5ar,5br,7ar,9r,11ar,11br,13ar,13br)-3a,5a,5b,8,8,11a-hexamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

C39H56O3 (572.4229)

3a,5a,5b,8,8,11a-hexamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl 3-(4-hydroxyphenyl)prop-2-enoate

C39H56O3 (572.4229)

(3s,4ar,6ar,6bs,8ar,12as,14ar,14br)-4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

C39H56O3 (572.4229)

(2z)-6-[3,7-bis(acetyloxy)-4-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-methylhept-2-enoic acid

C34H52O7 (572.3713)